Treatment of breast cancer brain metastases

被引:12
作者
Hofer, Silvia [1 ]
Pestalozzi, Bernhard C. [1 ]
机构
[1] Univ Zurich Hosp, Dept Oncol, CH-8091 Zurich, Switzerland
关键词
Brain metastasis; Breast cancer; Genetic subtype; Prognosis; Local treatment; Systemic treatment; RADIATION-THERAPY; STEREOTACTIC RADIOSURGERY; SINGLE METASTASES; PHASE-II; TRASTUZUMAB; RADIOTHERAPY; SURVIVAL; LAPATINIB; TRIAL; RISK;
D O I
10.1016/j.ejphar.2012.11.068
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Breast cancer represents the second most frequent cause of brain metastases. Treatment planning should consider several tumor and patient factors to estimate prognosis based on the Karnolsky Performance Status (RE'S), age, extent of extra-cerebral disease as well as genetic subtype. When systemic disease is under control patients with up to three metastases qualify for local therapy, such as surgical excision or stereotactic radiotherapy. After the local treatment the addition of whole brain radiation therapy may be postponed until disease progression in the brain is observed and overall survival will not be compromised. Asymptomatic brain metastases may be first approached with a systemic treatment to which the primacy tumor is considered to be sensitive. (C) 2013 Elsevier B.V. All rights reserved,
引用
收藏
页码:84 / 87
页数:4
相关论文
共 32 条
[1]   Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial [J].
Andrews, DW ;
Scott, CB ;
Sperduto, PW ;
Flanders, AE ;
Gaspar, LE ;
Schell, MC ;
Werner-Wasik, M ;
Demas, W ;
Ryu, J ;
Bahary, JP ;
Souhami, L ;
Rotman, M ;
Mehta, MP ;
Curran, WJ .
LANCET, 2004, 363 (9422) :1665-1672
[2]   Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases - A randomized controlled trial [J].
Aoyama, Hidefumi ;
Shirato, Hiroki ;
Tago, Masao ;
Nakagawa, Keiichi ;
Toyoda, Tatsuya ;
Hatano, Kazuo ;
Kenjyo, Masahiro ;
Oya, Natsuo ;
Hirota, Saeko ;
Shioura, Hiroki ;
Kunieda, Etsuo ;
Inomata, Taisuke ;
Hayakawa, Kazushige ;
Katoh, Norio ;
Kobashi, Gen .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 295 (21) :2483-2491
[3]  
Bachelot TD, 2011, J CLIN ONCOL S, V29
[4]   Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the metropolitan Detroit cancer surveillance system [J].
Barnholtz-Sloan, JS ;
Sloan, AE ;
Davis, FG ;
Vigneau, FD ;
Lai, P ;
Sawaya, RE .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) :2865-2872
[5]   Bevacizumab Safety in Patients with Central Nervous System Metastases [J].
Besse, Benjamin ;
Lasserre, Susan F. ;
Compton, Peter ;
Huang, Jane ;
Augustus, Stella ;
Rohr, Ulrich-Peter .
CLINICAL CANCER RESEARCH, 2010, 16 (01) :269-278
[6]  
BOOGERD W, 1992, CANCER, V69, P972, DOI 10.1002/1097-0142(19920215)69:4<972::AID-CNCR2820690423>3.0.CO
[7]  
2-P
[8]   Chemotherapy as primary treatment for brain metastases from breast cancer: analysis of 115 one-year survivors [J].
Boogerd, Willem ;
Groenveld, Femke ;
Linn, Sabine ;
Baars, Joke W. ;
Brandsma, Dieta ;
van Tinteren, Harm .
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2012, 138 (08) :1395-1403
[9]   Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial [J].
Chang, Eric L. ;
Wefel, Jeffrey S. ;
Hess, Kenneth R. ;
Allen, Pamela K. ;
Lang, Frederick F. ;
Kornguth, David G. ;
Arbuckle, Rebecca B. ;
Swint, J. Michael ;
Shiu, Almon S. ;
Maor, Moshe H. ;
Meyers, Christina A. .
LANCET ONCOLOGY, 2009, 10 (11) :1037-1044
[10]  
DEANGELIS L, 2000, DIS BREAST, P867